Navigation Links
Harborview Medical Center in Seattle Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
Date:1/10/2008

et="_new">http://www.cardinalhealth.com), including more than 40,000 employees around the world, the Cardinal Health Foundation is the focal point of the company's community relations efforts. The Foundation's mission is to advance and fund regional and national programs that improve access to and delivery of quality healthcare services. With annual revenues of $87 billion and operations on five continents, Cardinal Health serves the healthcare industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients.


'/>"/>
SOURCE Baxter International Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Novo Nordisk Appoints Alan C. Moses as Chief Medical Officer Worldwide
2. Symmetry Medical Expands Board of Directors
3. China Medical Technologies Completes Acquisition of BBE
4. NxStage Medical Announces Needle Supply Agreement with DaVita
5. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
6. Triage study challenges notions of emergency medical response to disaster
7. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
8. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
9. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
10. Inverness Medical Innovations Acquires ParadigmHealth
11. BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3